The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings?

The study of the genetics of complex human disease has met with limited success. Many findings with candidate genes fail to replicate despite seemingly overwhelming physiological data implicating the genes. In contrast, animal model studies of the same genes and disease models usually have more consistent results. We propose that one important reason for this is the ability to control genetic background in animal studies. The fact that controlling genetic background can produce more consistent results suggests that the failure to replicate human findings in the same diseases is due to variation in interacting genes. Hence, the contrasting nature of the findings from the different study designs indicates the importance of non-additive genetic effects on human disease. We discuss these issues and some methodological approaches that can detect multilocus effects, using hypertension as a model disease. This article contains supplementary material, which may be viewed at the BioEssays website at http://www.interscience.wiley.com/jpages/0265-9247/suppmat/index.html.

[1]  H. S. Kim,et al.  Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. , 1997, Hypertension.

[2]  G. Schlager,et al.  The role of dominance and epistasis in the genetic control of blood pressure in rodent models of hypertension. , 1991, Clinical and experimental hypertension. Part A, Theory and practice.

[3]  L. Peltonen,et al.  Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. , 1999, Hypertension.

[4]  F. Cappuccio,et al.  Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. , 1996, Journal of human hypertension.

[5]  R. Felder,et al.  Combinations of variations in multiple genes are associated with hypertension. , 2000, Hypertension.

[6]  J. Ménard,et al.  High human renin hypertension in transgenic rats. , 1997, Hypertension.

[7]  C. Rotimi,et al.  Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. , 1994, Hypertension.

[8]  M. Fiuza-Pérez,et al.  Effects of the angiotensinogen gene M235T and A(-6)G variants on blood pressure and other vascular risk factors in a Spanish population , 2000, Journal of Human Hypertension.

[9]  M. Soucek,et al.  Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertension. , 1998, Kidney international.

[10]  G. Rubin,et al.  Signal transduction downstream from Ras in Drosophila. , 1997, Cold Spring Harbor symposia on quantitative biology.

[11]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.

[12]  R. Ward,et al.  The angiotensin converting enzyme and blood pressure in Jamaicans. , 1997, American journal of hypertension.

[13]  S. Asai,et al.  Haplotype Analysis of the Human Renin Gene and Essential Hypertension , 2003, Hypertension.

[14]  C. Haley,et al.  Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 rats. , 1999, Kidney international.

[15]  T. Ogihara,et al.  Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. , 1997, Hypertension.

[16]  M. Garrett,et al.  Construction of a double congenic strain to prove an epistatic interaction on blood pressure between rat chromosomes 2 and 10. , 1998, The Journal of clinical investigation.

[17]  T. Niu,et al.  Angiotensinogen gene polymorphisms M235T/T174M: no excess transmission to hypertensive Chinese. , 1999, Hypertension.

[18]  David E. Goldberg,et al.  Genetic Algorithms in Search Optimization and Machine Learning , 1988 .

[19]  Steven C. Hunt,et al.  Molecular basis of human hypertension: Role of angiotensinogen , 1992, Cell.

[20]  T. Kurtz,et al.  Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure. , 1990, The Journal of clinical investigation.

[21]  M. Raizada,et al.  Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR. , 2000, Hypertension.

[22]  M. Fornage,et al.  Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. , 1998, Circulation.

[23]  D. Ganten,et al.  Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. , 1996, The American journal of physiology.

[24]  T. Kurtz,et al.  Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. , 1994, American journal of hypertension.

[25]  C. Sing,et al.  A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation. , 2001, Genome research.

[26]  M. Caulfield,et al.  Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. , 1995, The Journal of clinical investigation.

[27]  Z. Pausova,et al.  TA Repeat Variation, Npr1 Expression, and Blood Pressure: Impact of the Ace Locus , 2003, Hypertension.

[28]  J. Ott,et al.  Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease , 2002, The Pharmacogenomics Journal.

[29]  P. Frossard,et al.  An MboI two-allele polymorphism may implicate the human renin gene in primary hypertension. , 1998, Hypertension research : official journal of the Japanese Society of Hypertension.

[30]  PM Frossard,et al.  Haplotypes of the human renin gene associated with essential hypertension and stroke , 2001, Journal of Human Hypertension.

[31]  N. Hübner,et al.  Congenic rat strains are important tools for the genetic dissection of essential hypertension. , 2002, Seminars in nephrology.

[32]  K. Kodama,et al.  Association of a polymorphism at the 5'-region of the angiotensin II type 1 receptor with hypertension. , 2000, Annals of human genetics.

[33]  H. S. Kim,et al.  Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Boerwinkle,et al.  Context-dependent associations of the ACE I/D polymorphism with blood pressure. , 1999, Hypertension.

[35]  T. Saruta,et al.  Selective genotyping with epistasis can be utilized for a major quantitative trait locus mapping in hypertension in rats. , 2000, Genetics.

[36]  G. M. Lathrop,et al.  Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats , 1991, Nature.

[37]  A. Russ,et al.  Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension. , 1998, American journal of hypertension.

[38]  R H Myers,et al.  Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. , 1998, Circulation.

[39]  C. Sigmund,et al.  Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. , 1996, The Journal of clinical investigation.

[40]  M. Masu,et al.  Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Ogihara,et al.  Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. , 1998, American journal of hypertension.

[42]  D. Ganten,et al.  Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene , 1990, Nature.

[43]  H. Harn,et al.  Angiotensin I converting enzyme gene polymorphism in Chinese patients with hypertension. , 1997, American journal of hypertension.

[44]  D. Davis,et al.  Physiological significance of two common haplotypes of human angiotensinogen using gene targeting in the mouse. , 2002, Physiological genomics.

[45]  M. Phillips,et al.  Angiotensin II AT1A Receptor Antisense Lowers Blood Pressure in Acute 2-Kidney, 1-Clip Hypertension , 2001, Hypertension.

[46]  Eric S. Lander,et al.  Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat , 1991, Cell.

[47]  D. Grobbee,et al.  Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study , 1993, Journal of hypertension.

[48]  F. Cambien,et al.  Similar Frequencies of Renin Gene Restriction Fragment Length Polymorphisms in Hypertensive and Normotensive Subjects , 1990, Hypertension.

[49]  Jason H. Moore,et al.  Cellular Automata and Genetic Algorithms for Parallel Problem Solving in Human Genetics , 2002, PPSN.

[50]  B. Morris,et al.  Exclusion of angiotensinogen gene in molecular basis of human hypertension: sibpair linkage and association analyses in Australian anglo-caucasians. , 1999, American journal of medical genetics.

[51]  N. Schork,et al.  Extensions to quantitative trait locus mapping in experimental organisms. , 1996, Hypertension.

[52]  Y. Tseng,et al.  Lack of association of the angiotensin converting enzyme polymorphism with essential hypertension in a Chinese population. , 1997, American journal of hypertension.

[53]  T. Coffman,et al.  Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II. , 2000, Hypertension.

[54]  I. Borecki,et al.  Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study. , 1997, Annals of epidemiology.

[55]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[56]  H. S. Kim,et al.  Importance of quantitative genetic variations in the etiology of hypertension. , 2000, Kidney international.

[57]  Y. Yazaki,et al.  Comprehensive analysis of the renin–angiotensin gene polymorphisms with relation to hypertension in the Japanese , 2000, Journal of hypertension.

[58]  K. Kanmatsuse,et al.  Ventrolateral Medulla AT1 Receptors Support Blood Pressure in Hypertensive Rats , 2002, Hypertension.

[59]  Jean Tichet,et al.  Gene polymorphisms of the renin‐angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study , 1998, Journal of hypertension.

[60]  N. Markandu,et al.  Angiotensinogen Met235-->Thr polymorphism in a London normotensive and hypertensive black and white population. , 1994, Journal of human hypertension.

[61]  Hyung-Suk Kim,et al.  A genetically clamped renin transgene for the induction of hypertension , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. Ganten,et al.  The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects. , 1996, American journal of hypertension.

[63]  G. Rubin,et al.  A genetic screen for modifiers of a kinase suppressor of Ras-dependent rough eye phenotype in Drosophila. , 2000, Genetics.

[64]  Jason H. Moore,et al.  Power of multifactor dimensionality reduction for detecting gene‐gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity , 2003, Genetic epidemiology.

[65]  An Autosomal Bristle Modifier, Affecting a Sex-Linked Character , 1918, The American Naturalist.

[66]  E. Ritz,et al.  A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension , 1997, Journal of hypertension.

[67]  P. Mannon,et al.  Regulation of blood pressure by the type 1A angiotensin II receptor gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  S. Lavandero,et al.  Angiotensin I-converting enzyme gene polymorphism influences chronic hypertensive response in the rat Goldblatt model , 2002, Journal of hypertension.

[69]  A. Hingorani,et al.  Renin‐angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition , 1995, Journal of hypertension.

[70]  S. John,et al.  Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Curt D. Sigmund,et al.  Elevated Blood Pressure in Transgenic Mice With Brain-Specific Expression of Human Angiotensinogen Driven by the Glial Fibrillary Acidic Protein Promoter , 2001, Circulation research.

[72]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[73]  W. Spiering,et al.  Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocates study , 2003, Journal of hypertension.

[74]  B. Cheung,et al.  Angiotensinogen gene and hypertension in Chinese , 1997 .

[75]  X. Jeunemaître,et al.  Sib pair linkage analysis of renin gene haplotypes in human essential hypertension , 2004, Human Genetics.

[76]  K. Kodama,et al.  Association of a polymorphism at the 5′‐region of the angiotensin II type 1 receptor with hypertension , 2000 .

[77]  B. Morris,et al.  Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. , 1992, Biochemical and biophysical research communications.

[78]  L. Navar,et al.  Essential Role of AT1A Receptor in the Development of 2K1C Hypertension , 2002, Hypertension.

[79]  T. Ogihara,et al.  Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. , 2000, Life sciences.

[80]  Jason H. Moore,et al.  The Ubiquitous Nature of Epistasis in Determining Susceptibility to Common Human Diseases , 2003, Human Heredity.

[81]  E. Nanba,et al.  Angiotensinogen gene variation and hypertension in a cohort study in Japanese. , 2001, Journal of epidemiology.

[82]  L. Tiret,et al.  Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. , 1994, Hypertension.

[83]  L. Palmer,et al.  Genomewide scans of complex human diseases: true linkage is hard to find. , 2001, American journal of human genetics.

[84]  Jason H. Moore,et al.  A Cellular Automata Approach to Detecting Interactions Among Single-nucleotide Polymorphisms in Complex Multifactorial Diseases , 2001, Pacific Symposium on Biocomputing.

[85]  Y. Tseng,et al.  Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese , 1997, Journal of hypertension.

[86]  J. H. Moore,et al.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. , 2001, American journal of human genetics.

[87]  M. Garrett,et al.  Two closely linked interactive blood pressure QTL on rat chromosome 5 defined using congenic Dahl rats. , 2002, Physiological genomics.

[88]  D. Clayton,et al.  Linkage of the angiotensinogen gene to essential hypertension. , 1994, The New England journal of medicine.

[89]  J. Rapp,et al.  A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. , 1989, Science.

[90]  D. Fallin,et al.  Angiotensinogen Gene Haplotype and Hypertension: Interaction With ACE Gene I Allele , 2003, Hypertension.

[91]  Scott M. Williams,et al.  New strategies for identifying gene-gene interactions in hypertension , 2002, Annals of medicine.

[92]  Wei Wang,et al.  G protein-coupled receptor kinase 4 gene variants in human essential hypertension , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[93]  H. S. Kim,et al.  Genetic control of blood pressure and the angiotensinogen locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Calvin B. Bridges,et al.  Specific modifiers of eosin eye color in Drosophila melanogaster , 1919 .

[95]  D. Clayton,et al.  Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetes. , 2001, Genetics.

[96]  Ali G. Gharavi,et al.  Molecular Mechanisms of Human Hypertension , 2001, Cell.

[97]  Y. Yazaki,et al.  Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies. , 1999, Journal of hypertension.

[98]  R C Elston,et al.  Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. , 2001, American journal of human genetics.

[99]  P. Phillips The language of gene interaction. , 1998, Genetics.